TARS - Tarsus Pharmaceuticals, Inc.

QQQ $ 481.15 $ 6.24 (1.31 %)

DIA $ 409.09 $ 2.37 (0.58 %)

SPY $ 559.11 $ 5.30 (0.96 %)

TLT $ 97.90 $ 0.45 (0.46 %)

GLD $ 231.62 $ -0.38 (-0.16 %)

Previous Close

$ 26.51

Open

$ 25.77

Bid

$ 26.47 x 100

Ask

$ 26.52 x 100

Day's Range

$ 25.76 - $ 26.57

52 Week Range

$ 12.57 - $ 42.50

Volume

531,929

Average Volume

Market Cap

Beta (5Y Monthly)

$ 1.07

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-27-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-17-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-11-2022	03-31-2022	10-Q
11	03-14-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-11-2021	03-31-2021	10-Q
15	03-31-2021	12-31-2020	10-K
16	11-25-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Reiterates Outperform on Tarsu...
08/09/2024 15:27:17

Oppenheimer analyst Francois Brisebois reiterates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform and raises the pric...

Tarsus Pharmaceuticals Q2 2024 GAAP EPS $(...
08/08/2024 21:03:17

Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.88) per share which beat the analyst consensus estimate o...

why-saia-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Saia Shares Are Trading Lower? Here Ar...
07/26/2024 17:25:58

HC Wainwright & Co. Maintains Buy on Tarsu...
05/13/2024 15:07:10

HC Wainwright & Co. analyst Oren Livnat maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price t...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
05/13/2024 12:06:42

Barclays Maintains Overweight on Tarsus Ph...
05/10/2024 19:17:04

Barclays analyst Balaji Prasad maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Overweight and raises the price target ...

Analyst Ratings For Tarsus Pharmaceuticals
05/09/2024 20:00:14

Oppenheimer Maintains Outperform on Tarsus...
05/09/2024 16:46:32

Oppenheimer analyst Francois Brisebois maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform and raises the price...

top-5-health-care-stocks-that-could-sink-your-portfolio-in-q2

Top 5 Health Care Stocks That Could Sink Y...
05/09/2024 12:44:39

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

Tarsus Pharmaceuticals Q1 2024 GAAP EPS $(...
05/08/2024 20:33:24

Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate o...

Tarsus Strengthens Financial Position And ...
04/23/2024 12:31:09

Tarsus Prices $100M Public Offering Of 2,8...
03/01/2024 06:26:58

Tarsus Pharmaceuticals announced the pricing of an underwritten public offering of 2,812,500 shares of its common stock at a pu...

Tarsus Pharmaceuticals Reveals Proposed $1...
02/29/2024 21:47:14

Tarsus also intends to grant the underwriters a 30-day option to purchase up to an additional $15.0 million of shares of its co...

A Glimpse Into The Expert Outlook On Tarsu...
02/29/2024 12:00:55

Goldman Sachs Maintains Neutral on Tarsus ...
02/29/2024 11:08:25

Goldman Sachs analyst Andrea Tan maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Neutral and raises the price target f...

HC Wainwright & Co. Maintains Buy on Tarsu...
02/28/2024 19:04:31

HC Wainwright & Co. analyst Oren Livnat maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price t...

Barclays Maintains Overweight on Tarsus Ph...
02/28/2024 16:15:43

Barclays analyst Balaji Prasad maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Overweight and raises the price target ...

icu-medical-to-rally-around-28-here-are-10-top-analyst-forecasts-for-wednesday

ICU Medical To Rally Around 28%? Here Are ...
02/28/2024 13:07:42

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Oppenheimer Reiterates Outperform on Tarsu...
02/28/2024 12:48:48

Oppenheimer analyst Francois Brisebois reiterates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Outperform and raises the pric...